Hemagglutination Inhibition (HI) Assay<<Return to Search Results
Serological detection of total antibodies (IgM and IgG) directed towards the Eastern equine encephalitis (EEE) virus by Hemagglutination Inhibition (HI) assay.
- Eastern Equine Encephalitis
Serum. Minimum volume of 400 µL required.
2 mL screw cap tubes.
Store samples refrigerated or frozen until shipped for testing. Ship frozen samples on dry ice, and refrigerated samples on wet ice
Shipping of specimens shall be done by a TDG certified individual in accordance with TDG regulations. For additional information regarding classification of specimens for the purposes of shipping, consult either Part 2 Appendix 3 of the TDG Regulations or section 3.6.2 of the IATA Dangerous Goods Regulations as applicable.
For additional guidance on the transport of infectious substances in other languages, please click on the link below.
Suspected infection with eastern equine encephalitis virus.
Completed Viral Zoonoses requisition including sender laboratory name, address and telephone number. Patient name and / or identifier (specimen reference number), date of birth, test(s) requested, collection date of specimen, date of on-set of symptoms, and clinical and travel history of patient.
To demonstrate seroconversion, both acute and convalescent samples must be tested in parallel.
The HI assay is used to measure the level of antibodies in a patient’s serum that will prevent the agglutination of susceptible erythrocytes by inactivated antigens that are able to attach to the erythrocyte receptors on red blood cells. A fourfold or greater increase or decrease in titre between the acute phase and convalescent phase serum is considered to be diagnostic of infection with eastern equine encephalitis virus. Results are expressed as the reciprocal of antibody titre.
Due to the cross-reactive nature of anti-flavivirus antibodies, (i.e. Yellow Fever, dengue, Powassan, etc.) detection of total EEE specific antibody in a single serum sample is indicative of past or present exposure to this agent. However, a 4 fold rise or greater in HI antibody titre or neutralizing antibody titre is required to document a "confirmed case" of infection with associated illness.
Isolation of an arbovirus, detection of specific antibody by plaque reduction neutralization assay or detection of nucleic acid by real-time RT-PCR in a clinical specimen would constitute firm evidence of viral association with illness and provide "confirmed case" status.
14 Calendar days.
- Clarke, D.H. and Casals, J. Techniques for hemagglutination and hemagglutination-inhibitiion with arthropod-borne viruses. Am. J. Trop. Med. And Hyg. 1958; 7: 561-573.